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Probiotics have been recognized as vaccine adjuvants and therapeutic agents to treat
acute gastroenteritis in children. We previously showed that rice bran (RB) reduced
human rotavirus diarrhea in gnotobiotic pigs. Human noroviruses (HuNoVs) are the
major pathogens causing non-bacterial acute gastroenteritis worldwide. In this study,
Lactobacillus rhamnosus GG (LGG) and Escherichia coli Nissle 1917 (EcN) were first
screened for their ability to bind HuNoV P particles and virions derived from clinical
samples containing HuNoV genotype GII.3 and GII.4, then the effects of LGG+EcN and
RB on HuNoV infection and diarrhea were investigated using the gnotobiotic pig model.
While LGG+EcN colonization inhibited HuNoV shedding, probiotic cocktail regimens
in which RB feeding started 7 days prior to or 1 day after viral inoculation in the
LGG+EcN colonized gnotobiotic pigs exhibited high protection against HuNoV diarrhea
and shedding, characterized by significantly reduced incidence (89 versus 20%) and
shorter mean duration of diarrhea (2.2 versus 0.2 days), as well as shorter mean duration
of virus shedding (3.2 versus 1.0 days). In both probiotic cocktail groups, the diarrhea
reduction rates were 78% compared with the control group, and diarrhea severity was
reduced as demonstrated by the significantly lower cumulative fecal scores. The high
protective efficacy of the probiotic cocktail regimens was attributed to stimulation of IFN-
γ+ T cell responses, increased production of intestinal IgA and IgG, and maintenance
of healthy intestinal morphology (manifested as longer villi compared with the control
group). Therefore, probiotic cocktail regimens containing LGG+EcN and RB may
represent highly efficacious strategies to prevent and treat HuNoV gastroenteritis, and
potentially other human enteric pathogens.
Keywords: probiotics, rice bran, human norovirus, diarrhea, gnotobiotic pigs
Abbreviations: EC, Enterobacter cloacae; EcN, Escherichia coli Nissle 1917; Gn, gnotobiotic; HBGA, histo-blood group
antigen; HRV, human rotavirus; HuNoV, human norovirus; LA, Lactobacillus acidophilus; LB, Lactobacillus bulgaricus;
LGG, Lactobacillus rhamnosus GG; LR, Lactobacillus reuteri; MuNoV, murine norovirus; PID, post-infection day; PPD,
post-partum day; RB, rice bran; VLP, virus-like particle.
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INTRODUCTION
Human noroviruses, non-enveloped viruses with a positive-
strand RNA genome, are the major pathogens causing non-
bacterial acute gastroenteritis worldwide (Pringle et al., 2015).
In the United States, HuNoVs have replaced HRVs as the single
most common cause of viral gastroenteritis in children and adults
(Bresee et al., 2012; Payne et al., 2013). After approximately
1.2 days of incubation (Lee et al., 2013), HuNoV gastroenteritis
generally lasts for 2–3 days and consists of nausea, vomiting,
and diarrhea (Lopman et al., 2004). More severe and prolonged
illness can occur in specific risk groups, including infants, the
elderly, and immunocompromised patients (Murata et al., 2007;
Hall et al., 2012; Green, 2014). Given the tremendous disease
burden and economic loss associated with HuNoVs infection
(Patel et al., 2008; Ahmed et al., 2014), vaccines and therapeutics
are in great demand to prevent and treat these infections.
However, due to the lack of a robust culturing system and a
suitable small-animal model, HuNoVs vaccine development and
antiviral research have long been hampered. Promising vaccines
have focused on recombinant capsid proteins, including VLPs
and P particles (Kocher and Yuan, 2015). Appropriate animal
models are essential tools to facilitate investigation of vaccine
candidates and therapeutic strategies. Neonatal gnotobiotic
(Gn) pigs recapitulate the pathologic hallmarks of enteric viral
infection and associated immune responses in the gastrointestinal
tract of young children (Yang and Yuan, 2014). Currently, as
the only animal model that supports the oral route of HuNoV
infection, develops diarrhea, and sheds virus in feces, Gn pigs are
used to evaluate viral pathogenesis and vaccine efficacy with high
translational validity to humans (Cheetham et al., 2006; Bui et al.,
2013; Kocher et al., 2014).
Probiotic bacteria are increasingly recognized as vaccine
adjuvants and therapeutic agents to treat acute gastroenteritis
in children (Licciardi and Tang, 2011; Schnadower et al., 2015).
The potential mechanisms include competing with pathogens
for nutrients and colonization sites, producing antimicrobial
metabolites, enhancing protective immune responses, and
reducing intestinal permeability (Ng et al., 2009). Notably,
Gram-positive probiotics Lactobacillus spp. have been extensively
evaluated for their beneficial effects against viral infection and
diseases. These include reducing HRV and vesicular stomatitis
virus infection in cell cultures (Botic et al., 2007; Maragkoudakis
et al., 2010) and promoting HRV-specific immune responses,
which contribute to shortened HRV-induced diarrhea in animal
models (Zhang et al., 2008; Wen et al., 2014, 2015) and
human clinical trials (Guandalini et al., 2000; Sindhu et al.,
2014; Szajewska et al., 2014). Gram-negative EcN is also a
well-characterized probiotic used to treat diarrhea in infants
and young children (Henker et al., 2007, 2008), as well as
in neonatal large animals (von Buenau et al., 2005; Schroeder
et al., 2006). The beneficial health effects are mediated via
improving intestinal barrier function (Hering et al., 2014)
or moderating inflammatory responses (Splichalova et al.,
2011), which could protect Gn piglets from lethal infection
of Salmonella Typhimurium (Splichalova et al., 2011). In
addition, EcN was recently shown to have HRV-binding and
immunomodulatory properties, resulting in significantly reduced
HRV infection and diarrhea in Gn pigs (Kandasamy et al., 2016).
Probiotics can act as adsorbents for HuNoV P particles, and
the presence of L. casei BL23 and EcN might inhibit P particle
attachment to epithelial cells (Rubio-del-Campo et al., 2014).
Enterobacter cloacae (EC) is a commensal bacterium that can
bind to HuNoV by surface HBGA and inhibit HuNoV infectivity
in Gn pigs (Miura et al., 2013; Lei et al., 2016b). Taken together,
diarrhea-reducing probiotics may inhibit HuNoV infectivity
in vivo, most likely by the binding between bacteria and virions.
Rice bran, an underutilized by-product of rice milling,
contains a variety of prebiotic and bioactive components
that modulate gut microbiota and potentially prevent chronic
diseases, including diabetes, cancer, metabolic syndrome, and
cardiovascular disease (Sheflin et al., 2015). In mouse studies,
dietary RB feeding increased production of fecal and serum
IgA (Henderson et al., 2012), and RB glycoproteins ameliorated
cyclophosphamide-induced immunosuppression by restoring
splenic lymphocytes (Park et al., 2016), indicating that RB
promoted the development of mucosal and systemic adaptive
immunity. Chemically engineered RB glucans possessed anti-
cytomegalovirus activity by blocking viral entry of target
cells (Ray et al., 2013). Recently, therapeutic effects of
RB in inhibiting enteric infections and reducing diarrhea
have been gaining attention. In a clinical trial, Biobran
(modified arabinoxylan RB) improved irritable bowel syndrome
symptoms, presumably resulting from its anti-inflammatory
and/or immunomodulatory effects (Kamiya et al., 2014). In
our previous Gn pig studies, dietary RB feeding significantly
enhanced HRV vaccine immunogenicity and reduced HRV-
induced diarrhea (Yang et al., 2014). RB could also protect
against HRV diarrhea in the presence of probiotics by preventing
intestinal epithelial damage and promoting innate immune
responses (Yang et al., 2015). Therefore, its beneficial effects on
gastrointestinal health support RB as a promising agent against
HuNoV infection.
In this study, aiming to develop an effective and ready-
to-use anti-HuNoV therapeutic strategy, we first screened a
group of probiotics to identify the virus-binding bacteria using
HuNoV P particles and native virions. Subsequently, probiotics
and RB were evaluated individually or combined as cocktail
regimens for their effects on HuNoV infection and diseases in
the well-established Gn pig model (Bui et al., 2013). Finally, the
mechanisms of antiviral and diarrhea-reducing activities from
those treatments were explored.
MATERIALS AND METHODS
Viruses and Bacteria
A human stool sample containing the HuNoV GII.4/2006b
variant 092895 (GenBank KC990829) was collected in 2008 at
the Cincinnati Children’s Hospital Medical Center from a child
with norovirus gastroenteritis. The sample pool was processed
as an oral inoculum for HuNoV infection studies in Gn pigs
(Bui et al., 2013). A human stool sample containing the HuNoV
GII.3/20110200 (GenBank KX355506) was collected in 2011 at
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the Thai Binh Pediatric Hospital (Thai Binh province, Vietnam)
from a female child with norovirus gastroenteritis. L. reuteri
(ATCC 23272), L. acidophilus (strain NCFM), L. rhamnosus GG
(ATCC 53103), and L. bulgaricus (ATCC 11842) were cultured in
lactobacilli MRS broth (Neogen Corporation) anaerobically using
BBLTM GasPakTM jar system with Anaerobe Sachets (BD) under
static condition at 37◦C. EcN (a gift from Dr. Jun Sun, Rush
University, Chicago, IL, USA) and Enterobacter cloacae (ATCC
13047) were cultured in Luria Bertani medium at 37◦C and in
nutrient broth at 30◦C, respectively, with shaking at 250 rpm.
Purification of HuNoVs and VP1
Sequencing
The pooled human stools containing HuNoVs were diluted
10-fold with diluent #5 (Minimal Essential Medium with 1%
penicillin-streptomycin and 1% HEPES) and mixed thoroughly
with an equal volume of Vertrel XF (Miller-Stephenson), and
viruses were purified by CsCl gradient centrifugation as described
previously (Guix et al., 2007). VP1 of GII.4/2006b variant
092895 was cloned and sequenced previously (Kocher et al.,
2014). GII.3/20110200 viral RNA was extracted from the purified
virus by TRIzol LS and reverse transcribed by SuperScript III
Reverse Transcriptase (Thermo Fisher Scientific) using universal
GII.3 reverse primer 5′-TAG CCC CTG CAT TAA CTA-3′ and
following the manufacturer’s instructions. The GII.3 VP1 was
cloned by a nested PCR with primer set 1 (forward: 5′-TGA
GCA CGT GGG AGG GCG-3′ and reverse: 5′-TAG CCC CTG
CAT TAA CTA-3′) and primer set 2 (forward: 5′-CAC CAT GAA
GAT GGC GTC GAA T-3′ and reverse: 5′-TTA TTG AAT CCT
TCT ACG CC-3′) into pENTR directional TOPO vector (Thermo
Fisher Scientific). The GII.3 VP1 fragment in the recombinant
plasmids were sequenced by Virginia Bioinformatics Institute at
Virginia Tech, and the predominant sequence was used for the
preparation of P particles.
P Particles and Transmission Electron
Microscopy
The region coding for the P domain was amplified from
the recombinant plasmids containing VP1 capsid gene of
HuNoV GII.3 or GII.4 as described above. The P domains
were cloned into prokaryotic expression vector pET21a (EMD
Millipore) as previously described (Rubio-del-Campo et al.,
2014). A 6×His-Tag was incorporated to the N-terminus of
P proteins by forward primers, and a cysteine-rich peptide
CDCRGDCFC was incorporated to the C-terminus of P proteins
by reverse primers to enhance the P particle stability (Tan and
Jiang, 2005). P proteins were expressed in E. coli strain BL21
(New England Biolabs) and purified via HisPur Ni-NTA Spin
Columns (Thermo Fisher Scientific) following the manufacturer’s
instructions. Protein production was monitored by SDS-PAGE
and InVision His-tag In-gel Stain (Thermo Fisher Scientific).
Protein concentrations were measured spectroscopically by
Quick StartTM Bradford protein assay (Bio-Rad). Electron
microscopy formvar carbon square grids (Electron Microscopy
Sciences) were pretreated with 1% aqueous Alcian blue for 5 min.
After washes, P particles of genotype GII.3 or GII.4 were diluted
in PBS to 5 µg/ml and absorbed to the grids for 1 min. The grids
were stained with 3% phosphotungstic acid pH 7.0 for 1 min and
viewed with a JEOL JEM 1400 transmission electron microscopy.
Binding of P Particles and Virions to
Bacteria
After the initial inoculation into fresh culture medium, bacteria
were grown overnight and sub-cultured at 1:50 for 2–3 h until
OD600 reached 0.4–1.0, which was the log phase of growth.
Bacteria were washed three times and resuspended with PBS to
an OD600 of 1.0. Then 10 µg P particles or 106 viral genome
copies of purified HuNoVs were incubated with 1 ml bacteria
for 1 h at 37◦C, then the mixture was centrifuged and washed
three times with PBS. To measure the remaining P particles
attached to bacteria, the bacterial pellets were resuspended
with 100 µl Laemmli sample buffer (Bio-Rad) and boiled for
10 min, and 20 µl of sample was loaded to 10% SDS-PAGE gel
and analyzed by Western Blot using HRP conjugated anti-His-
Tag antibody (MA1-21315-HRP, Thermo Fisher Scientific). To
measure the remaining virions, the total RNA of the bacterial
pellets was extracted by 750 µl TRIzol LS, and HuNoV genomes
were detected by a one-step TaqMan qRT-PCR with primers
targeting all GII viruses (Kageyama et al., 2003; Lei et al., 2016a).
For controls, Enterobacter cloacae were heat-killed at 65◦C for
40 min, then blocked with 5 µl of A antigen antibody (sc-69951,
Santa Cruz) and H antigen antibody (sc-52369, Santa Cruz) at
37◦C for 20 min before adding P particles or virions.
Gnotobiotic Pigs and Treatment Groups
Near-term Yorkshire cross-breed pigs were derived via
hysterectomy by veterinarians and maintained in sterile
isolator units as described previously (Meyer et al., 1964).
Neonatal Gn pigs (male and female) were randomly assigned to
the five treatment groups upon derivation: cocktail-7d (n = 5),
cocktail+1d (n = 5), RB-7d (n = 4), LGG+EcN (n = 5),
control (n = 9). To initiate the colonization of LGG and EcN,
104 CFU of each were mixed in five ml of Minimal Essential
Medium and administered orally to pigs on PPD 3, 5, and 7.
The low dosage was chosen on purpose to be well below the
therapeutic practice (109 to 1012 CFU). LGG and EcN fecal
shedding were determined by rectal swab sampling of pig feces
and enumeration of colonies grown on media agar plates as
described previously (Yang et al., 2015). For RB feeding of pigs,
heat-stabilized and gamma-irradiated RB (Calrose variety) was
added to pigs’ milk diet by replacing 10% daily calorie intake
(Yang et al., 2015). Daily feeding started 7 days prior to or 1 day
after HuNoV inoculation until euthanasia. All pigs were orally
inoculated on PPD33 with 6.43 × 105 viral genome copies of
HuNoV GII.4/2006b variant 092895. To reduce gastric acidity,
four ml 200 mM sodium bicarbonate were given to pigs 15 min
prior to inoculation. Fecal consistency and virus shedding were
assessed daily until euthanasia on PPD40 where blood, tissues,
and intestinal contents were collected. Fecal consistency scores
were obtained based on previous scaling system (Bui et al., 2013),
and fecal virus shedding was measured by a one-step TaqMan
qRT-PCR as described previously (Lei et al., 2016a).
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Flow Cytometry Analysis
Mononuclear cells (MNCs) were isolated from the duodenum,
ileum, spleen, and blood as described previously (Yuan et al.,
2008). 2× 106 of MNCs were restimulated in vitro with P particle
(12 µg/ml for the spleen and 6 µg/ml for others), positive control
PHA (10 µg/ml), or mock control in E-RPMI media for 17 h
at 37◦C. Brefeldin A (B6542, Sigma-Aldrich, 5 µg/ml) and anti-
CD49d monoclonal antibody (561892, BD Biosciences, 1 µl/ml)
were added at 12 h post-incubation to block the secretion of
cytokines and enhance the stimulation, respectively. IFN-γ+
CD4+ and CD8+ T cells were quantified by flow cytometry
as described previously (Yuan et al., 2008). Isotype matched
irrelevant antibodies were included as negative gate controls.
Mock-stimulated samples indicate the total IFN-γ+ T cells, while
the increased cell populations of P particle-stimulated over mock-
stimulated samples indicate HuNoV-specific IFN-γ+ T cells.
ELISA for Total Immunoglobulin and
IFN-γ
The total immunoglobulin (Ig) titers in intestinal contents
were determined by ELISA as described previously (Lei et al.,
2016a). Intestinal IFN-γ titers were measured by Swine IFN-γ
VetSetTM ELISA development Kit (Kingfisher Biotech) following
the manufacturer’s instructions.
Jejunum Histopathology
Jejunum tissue was collected after pig euthanasia, fixed in 4%
paraformaldehyde for 12–16 h, paraffin embedded, sectioned
into 5 µm slices and placed on positively charged slides, for
routine H&E staining. A pathologist who was blinded to the
sample identifications evaluated the villus length using an ocular
micrometer under a light microscope.
Ethical Statement
Stool collection protocols were approved by the Institutional
Review Boards of the Cincinnati Children’s Hospital Medical
Center (IRB#: 2008-1131) and the National Institute of Hygiene
and Epidemiology – Vietnam (IRB#: 15-IRB), written consent
was provided by parents or guardians of the children. Animal
experimental protocols were approved by the Institutional
Animal Care and Use Committee at Virginia Tech (IACUC
protocol: 13-187-CVM and 14-108-CVM). All sample collection
and experimental procedures were conducted in accordance with
the approved guidelines.
Statistics
Statistics were performed using GraphPad Prism 6.0 (GraphPad
Software) with analyses indicated in table notes and figure
legends. Statistical significance was determined at the level of
P < 0.05.
RESULTS
Probiotic Bacteria Bind to HuNoVs
Although HuNoV genotype GII.4 accounts for the most
global acute gastroenteritis outbreaks (Pringle et al., 2015),
GII.3 is emerging and becoming predominant in some
underdeveloped areas (Liu et al., 2014; Van Trang et al.,
2014; Ayouni et al., 2015). To explore the interactions between
HuNoVs and probiotics, we first cloned the capsid VP1
genes of GII.3 and GII.4 from clinical stool samples, then
the P-domains were cloned and proteins were expressed
with N-terminal 6×His-Tag to facilitate their detection and
purification (Figure 1A). The formation of P particles was
not compromised as indicated by a negative staining electron
microscopy (Figure 1B).
P particles were first used as a model to determine HuNoVs
interactions with probiotics, including a Gram-negative strain
EcN and four Gram-positive lactobacilli strains, i.e., L. reuteri
(LR), L. acidophilus (LA), L. rhamnosus GG (LGG), and
L. bulgaricus (LB). Since EC can bind to HuNoVs specifically
by surface HBGA (Miura et al., 2013), native EC was used
as a positive control and HBGA A&H antibodies-blocked EC
was a negative control in the binding assays. After incubation
of P particles and bacteria, the P particles remaining on the
bacterial surface were quantified by Western Blot using anti-
His-Tag antibody. The results showed that all the tested bacteria
were able to bind to both GII.3 and GII.4 P particles, and
lactobacilli strains had significantly higher binding capacity
than those of EcN and EC (Figure 1C). Additionally, LA was
stronger than LR in binding to GII.3 P particle, while EcN
was weaker than EC. The four lactobacilli strains did not differ
from each other in binding to GII.4 P particle, and neither did
EcN and EC (Figure 1C). Similarly, the binding assays were
performed using HuNoV virions purified from stool samples.
Unlike the P particles, GII.3 virions had comparable binding
to all tested bacteria except for the higher binding to LGG,
whereas GII.4 virions shared the binding pattern with P particle
except for the lower binding to LGG and higher binding to LB
(Figure 1D). These data suggest that probiotic bacteria can bind
to HuNoVs.
LGG+EcN Inhibited HuNoV Shedding
and RB Reduced Diarrhea in Gn Pigs
To develop a ready-to-use anti-HuNoV therapeutic strategy,
LGG and EcN were chosen for the evaluation of their potential
antiviral effects in the Gn pig model of HuNoV infection
and diarrhea, since they could bind HuNoVs in vitro and are
commercially available as diarrhea-reducing probiotics. Previous
study showed that RB protected against HRV-induced diarrhea
in the presence of LGG and EcN (Yang et al., 2015), we tested
RB feeding and/or LGG+EcN co-colonization in five treatment
groups in this study: cocktail-7d (n = 5), pigs were pre-
colonized with LGG and EcN, RB feeding started 7 days prior
to HuNoV inoculation; cocktail+1d (n = 5), pigs were pre-
colonized with LGG and EcN, RB feeding started 1 day after
virus inoculation; RB-7d (n = 4), RB feeding started 7 days prior
to inoculation; LGG+EcN (n = 5), pigs were colonized with
LGG and EcN only; Control (n = 9), non-RB fed and non-
LGG+EcN colonized. All pigs were inoculated with a HuNoV
GII.4/2006b variant 092895 on PPD33/PID0 and euthanized on
PID7 (Figure 2A).
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FIGURE 1 | Probiotic bacteria bind to HuNoV P particles and virions. (A) SDS-PAGE analysis of the 6×His tagged P proteins expressed and purified from the
prokaryotic system. Lane 1, protein standard marker. Lanes 2 and 3, GII.3 and GII.4 P proteins. (B) Transmission electron micrographs of P particles. Scale bar,
200 nm. (C) Probiotic bacteria bind to P particles. Bottom panels, representative Western Blot using anti-His-Tag antibody showing the P particles bound to
bacteria. Top panels, four independent experiments were analyzed by Image J. The relative bindings are referred to that of EC. (D) Probiotic bacteria bind to virions.
The virions bound to bacteria were quantified by qRT-PCR for viral genomes. The experiments were repeated three times independently. Controls were heat-killed
and A&H antigen antibodies-blocked EC. Data are presented as mean ± SEM. Statistics was determined by one-way analysis of variance (ANOVA). Different letters
indicate significant differences among groups (P < 0.05), while shared letters indicate no significant difference.
Fecal consistency and virus shedding were assessed daily after
the HuNoV inoculation (Supplementary Figure S1). The results
summarized in Table 1 showed that compared to the control
group, LGG+EcN group had similar rates of HuNoV diarrhea
(89 versus 60%), yet undetectable HuNoV shedding. RB-7d group
had a slightly shorter mean duration of diarrhea (2.2 versus
1.3 days) and significantly delayed shedding onset (2.8 versus
6.3 days). More importantly, cocktail-7d and cocktail+1d groups
had a significantly lower incidence (20%), delayed onset (3.9
versus 7.0 and 7.2 days, respectively), shorter mean duration of
diarrhea (2.2 versus 0.2 days), and shorter mean duration of
virus shedding (3.2 versus 1.0 days). In both cocktail groups,
the diarrhea reduction rates were 78% [1 – (% of treated
pigs with diarrhea/% of control pigs with diarrhea)], and the
reduced severity of diarrhea was also shown by the significantly
lower cumulative fecal scores (Figure 2B). Interestingly, only the
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FIGURE 2 | Design and summary of Gn pig study. (A) Experimental timeline. PPD, post-partum day; PID, post-inoculation day. Cumulative fecal scores (B) and
shedding (C) are shown as area under curve from daily measurements of individual pigs (Supplementary Figure S1). (D) Mean peak virus shedding titers from PID1
to PID7 in individual pigs. Sample sizes are shown in Table 1. Data are presented as mean ± SEM. Dashed lines indicate limit of detection. Statistics were
determined by Kruskal–Wallis test. Different letters indicate significant differences among groups (P < 0.05), while shared letters indicate no significant difference.
LGG+EcN group had significantly reduced cumulative and peak
virus shedding compared to the control group. RB feeding with or
without LGG+EcN colonization did not significantly alter virus
shedding pattern, except that shedding in the cocktail+1d group
trended lower when compared to the other RB fed groups and the
controls (Figures 2C,D).
RB Promoted the Colonization of EcN
but not LGG in Gn Pigs
The colonization of LGG and EcN in Gn pigs was confirmed
by their fecal shedding on PPD26 (Figures 3A,B). After the
beginning of RB feeding on PPD26 in the cocktail-7d group and
on PPD34 in the cocktail-1d group, LGG fecal shedding appeared
to decrease in both groups, however, statistical significance was
not observed for these differences (Figure 3A). On the other
hand, RB feeding significantly increased EcN fecal shedding
in the cocktail-7d group and slightly in the cocktail-1d group
(Figure 3B). Taken together, these results indicate the differential
effects of RB on the co-colonization of probiotic bacteria.
LGG+EcN and RB Stimulated the
Production of IFN-γ+ T Cells
To elucidate the mechanisms of the inhibitory effects of
LGG+EcN and RB on HuNoV infection and diarrhea, their
TABLE 1 | Incidence of diarrhea and fecal virus shedding in Gn pigs after HuNoV GII.4 challengea.
Group n Diarrheab Virus sheddingb
Pigs with
diarrhea (%)∗
Mean days to
onset (SEM)∗∗
Mean duration
days (SEM)∗∗
Pigs shedding
virus (%)∗
Mean days to
onset (SEM)∗∗
Mean duration
days (SEM)∗∗
Cocktail-7d 5 1 (20%)A 7.0 (1.0)A 0.2 (0.2)A 4 (80%)A 4.0 (1.2)AB 1.0 (0.3)AB
Cocktail+1d 5 1 (20%)A 7.2 (0.8)A 0.2 (0.2)A 5 (100%)A 4.8 (0.2)AB 1.0 (0)A
RB-7d 4 3 (75%)AB 3.3 (1.6)AB 1.3 (0.5)AB 3 (75%)A 6.3 (0.8)A 1.5 (0.6)AB
LGG+EcN 5 3 (60%)AB 4.0 (1.6)AB 1.8 (1.1)AB 0B 8.0 (0)C 0C
Control 9 8 (89%)B 3.9 (0.7)B 2.2 (0.4)B 8 (89%)A 2.8 (0.8)B 3.2 (0.9)B
aGn pigs were inoculated with a HuNoV GII.4 2006b variant 092895 at 33 days of age. Diarrhea and virus shedding were monitored by daily rectal swab sampling and
RT-qPCR after inoculation. Calculation included all pigs in each group from PID1 to PID7.
b If diarrhea or virus shedding was not observed, the days to onset was recorded as 8 and the duration days was recorded as 0 for statistical purposes.
∗Fisher’s exact test or ∗∗Kruskal–Wallis test was used for comparisons. Different letters indicate significant differences among treatment groups (P < 0.05), while shared
letters indicate no significant difference.
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FIGURE 3 | LGG and EcN fecal shedding. Pig feces were collected by rectal swab and suspended in PBS. The concentrations of LGG (A) and EcN (B) were
determined in serial dilution of fecal samples and enumeration of colony forming unit (CFU) grown on MRS or LB media agar plates. Sample sizes are shown in
Table 1. Data are presented as mean ± SEM. Statistics were determined by Kruskal–Wallis test. NS, not significant, ∗P < 0.05.
FIGURE 4 | LGG+EcN and RB stimulated IFN-γ+ T cell responses. (A) Gating strategies for IFN-γ+ CD3+CD4+ (Th) cells and CD3+CD8+ (CTL) cells.
Representative dot plots showing frequencies of HuNoV-specific (P particle stimulated) and non-specific (mock stimulated) IFN-γ+ T cells in ileum isolated from
LGG+EcN colonized Gn pigs. SSC-A, side scatter area; APC, allophycocyanin; FITC, fluorescein isothiocyanate; SPRD, spectral red; PE, phycoerythrin. (B)
Non-specific IFN-γ+ T cells in intestinal (duodenum, ileum) and systemic (spleen, blood) tissues on PID7. Sample sizes are shown in Table 1. Data are presented as
means ± SEM. Statistics were determined by Kruskal–Wallis test. NS, not significant, ∗P < 0.05, ∗∗P < 0.01.
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FIGURE 5 | IgA, IgG, and IFN-γ levels in intestinal contents after HuNoV infection. Total IgA (A) and IgG (B) titers in small and large intestinal contents (SIC
and LIC) were measured by ELISA. (C) IFN-γ concentration in LIC was measured by ELISA. Sample sizes are shown in Table 1. Data are presented as
mean ± SEM. Statistics were determined by Kruskal–Wallis test. Different letters indicate significant differences among groups (P < 0.05), while shared letters
indicate no significant difference.
immunomodulatory roles were first assessed regarding effector T
cells. After euthanasia on PID7, MNCs were isolated from both
intestinal and systemic lymphoid tissues, and the frequencies
of IFN-γ+ CD4+ and CD8+ T cells were determined by
flow cytometry (Figure 4A). MNCs were stimulated with P
particle to detect HuNoV-specific IFN-γ+ T cells, which was
the increased frequency compared to the mock stimulated
sample. For pigs in the control, LGG+EcN, and RB-7d
groups, no significant increase of IFN-γ+ T cells was observed
in P particle stimulated MNCs (Figure 4A and data not
shown), suggesting low or short-term HuNoV-specific IFN-
γ+ T cell responses. However, compared with control pigs,
both LGG+EcN colonization and RB feeding significantly
increased frequencies of non-specific total IFN-γ+ T cells
(Figure 4B). In addition, compared with the LGG+EcN group,
the RB-7 group had significantly higher frequencies of IFN-γ+
CD8+ T cell population in ileum and IFN-γ+ CD4+ T cell
population in all assayed lymphoid tissues (duodenum, ileum,
spleen, and blood; Figure 4B), indicating that RB has strong
stimulatory effects on total IFN-γ+ T cell responses, which
may contribute to the reduction of HuNoV diarrhea in Gn
pigs.
Probiotics plus RB Cocktail Regimens
Enhanced Gut Immunity
The immunomodulatory roles of LGG+EcN and RB on gut
immunity were evaluated by testing total intestinal IgA, IgG, and
IFN-γ levels, since PID 7 is too early to detect virus-specific
IgA and IgG antibody responses. Compared with the control
group, the cocktail-7d, cocktail+1d, and LGG+EcN groups had
significantly higher IgA titers in both small and large intestinal
contents (SIC and LIC), but the increase was not observed in
the RB-7d group (Figure 5A), indicating that LGG+EcN but
not RB enhanced the production of IgA. The cocktail-7d and
cocktail+1d groups had significantly higher IgG titers in both
SIC and LIC, whereas no differences were observed in either
the LGG+EcN or RB groups (Figure 5B). Consistent with the
strong stimulation of RB on total IFN-γ+ T cells (Figure 4B),
significantly higher IFN-γ concentrations were detected in
LIC from the cocktail-7d, cocktail+1d, and RB-7d groups
(Figure 5C). In all, cocktail regimens remarkably enhanced gut
immunity in Gn pigs by secretion of intestinal immunoglobulins
and interferon, which might provide protection against HuNoV
infection.
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FIGURE 6 | LGG+EcN and RB are associated with longer villi. (A–E) Representative images of H&E stained jejunum showing the villi length in the five groups.
Scale bar, 0.25 mm. (F) 30 random villi including all pigs in each group were measured to quantify the villi length. Data are presented as means with individual points.
Statistics were determined by Kruskal–Wallis test. Different letters indicate significant differences among groups (P < 0.05), while shared letters indicate no significant
difference.
Probiotics plus RB Cocktail Regimens
Increased Jejunal Villi Length
Villus blunting is a major manifestation of impaired intestinal
health, such as in Crohn’s disease (Cadwell et al., 2010),
celiac disease (Chand and Mihas, 2006), and virus-induced
gastroenteritis (Hodges and Gill, 2010). To examine the beneficial
effects of LGG+EcN and RB on the health of small intestine
in Gn pigs, sections of jejunum were stained with H&E and
evaluated for all the treatment groups after euthanasia. Compared
with control, both LGG+EcN colonization and RB feeding
were associated with significantly longer jejunal villus length.
Their stimulatory roles might be additive as the two cocktail
groups displayed greater villus length than either single treatment
(Figure 6). These data indicate that the cocktail regimens
promote the growth and health of intestinal epithelium, which
might contribute to the protection of HuNoV-induced disease.
DISCUSSION
Robust cell culture and animal models have long been lacking
for HuNoV propagation, as a result, clinical stool samples
from patients are the only resource for HuNoV infection
studies. P particles are promising surrogates as they exhibit
surface conformation and receptor-binding profiles similar to
the corresponding VLPs (Tan et al., 2008), and they have been
validated as an in vitro model to evaluate viral binding with
probiotics (Rubio-del-Campo et al., 2014). In this study, we first
prepared HuNoV GII.3 and GII.4 P proteins, which displayed
double bands as expected (Figures 1A,C; Rubio-del-Campo et al.,
2014). The P particle structures were observed under electron
microscopy. The binding assays with both P particles and native
virions showed that their binding capacity with Gram-negative
EcN was lower than that with Gram-positive lactobacilli, EcN
was still included in this study due to its commercial availability,
diarrhea-reducing properties on enteric pathogens such as HRV
(Kandasamy et al., 2016), and potential inhibition of HuNoV
attachment to epithelial cells (Rubio-del-Campo et al., 2014).
It is likely that differential cell surface composition of Gram-
negative and Gram-positive bacteria determines the observed
differences, although surface components that are responsible for
viral binding remain to be identified.
Bacterial microbiota was shown to facilitate persistent and
acute MuNoV infection in mice (Jones et al., 2014; Baldridge
et al., 2015), but the effects of different bacteria on MuNoV
infectivity might vary as lactobacilli could inhibit MuNoV
infection in vitro using RAW264.7 cell culture model and
vitamin A inhibited MuNoV replication in mice by upregulating
lactobacilli in gut microbiota (Lee and Ko, 2016). In this study,
after HuNoV inoculation in Gn pigs colonized with LGG+EcN,
virus fecal shedding was below the limit of detection, indicating
significant inhibition on HuNoV infection by their colonization.
Similar to the reduced virus shedding but unaffected incidence
of diarrhea observed in EC colonized Gn pigs in the previous
study (Lei et al., 2016b), LGG+EcN colonization did not
alter the occurrence of diarrhea, suggesting that HuNoV
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gastroenteritis could be induced by extremely low viral loads
and that anti-HuNoV agents inhibiting viral replication may
have insufficient efficacy in reducing the disease. Given that
bacterial anti-HuNoV capacity might depend on the extent
of viral retention ability, it is likely that LGG plays a more
important role on the inhibition of HuNoV infectivity than EcN,
since LGG has a greater HuNoV-binding ability, but further
investigations will be required to clarify the effects of LGG
or EcN mono-colonization on HuNoV infection. Nevertheless,
cocktail regimens containing LGG and EcN offer great promise
to simultaneously protect against HuNoV and HRV infection
(Kandasamy et al., 2016).
Although, RB was shown to promote the colonization of
lactobacilli in mice (Henderson et al., 2012), LGG fecal shedding
was lower after RB feeding in cocktail groups in this study.
When colonized together with EcN in Gn pigs, LGG fecal
shedding and concentration in intestinal tissues trended toward
lower than those of single colonization (Kandasamy et al., 2016),
suggesting that the presence of EcN might inhibit the growth of
LGG. Thus, it is likely that higher growth of EcN led to lower
growth of LGG after RB feeding, and underlying mechanisms
utilized by EcN need to be identified, such as competing for the
nutrients and colonization sites, improving intestinal barrier, and
modulating immune responses (Splichalova et al., 2011; Hering
et al., 2014). In all, higher protective efficacy against HuNoV
shedding and diarrhea might be achieved only if RB and LGG
are given.
Effector T cells are a crucial immune component to eliminate
viral infected cells, and their responses in the small intestine
are associated with protective immunity against HRV (Yuan
et al., 2008). However, HuNoV infection or P particle vaccination
did not significantly stimulate virus-specific IFN-γ+ CD4+ or
CD8+ T cell responses (Kocher et al., 2014), and neither
did LGG+EcN colonization nor RB feeding in this study.
Still, significantly increased frequencies of non-specific IFN-
γ+ T cells were observed especially after RB feeding, which
might be correlated with the diarrhea-reducing property of
RB, but a significant reduction in virus shedding was not
observed along with the enhanced T cell responses in the RB-
7d group, which was similar to our previous study on HRV
(Yang et al., 2014). For the cocktail regimens, the intestinal
IgA was increased by LGG+EcN alone, while the increased
intestinal IgG might have been induced by the synergism
between LGG+EcN and RB. The additive effects of the probiotics
and RB appeared to be associated with longer jejunal villus
length.
In this study, the cocktail-7d group displayed a 78% reduction
of diarrhea, as well as significantly shortened duration of diarrhea
and virus shedding after HuNoV challenge, indicating the
regimen is an effective preventive measure. In addition, similar
effects in reducing diarrhea and virus shedding were observed
in the cocktail+1d group, in which RB feeding started 1 day
after HuNoV challenge, thus this regimen could be considered
as a therapeutic strategy to treat HuNoV gastroenteritis. The
first HuNoV vaccine candidate evaluated in clinical trials was an
adjuvanted monovalent GI.1 VLP, which provided 47 and 26%
protection against Norwalk virus gastroenteritis and infection
compared with the placebo group, respectively (Atmar et al.,
2011). A bivalent VLP-based vaccine containing both GI.1 and
GII.4 components is under development as well, and human
clinical trials showed a 52% reduction in vomiting and/or
diarrhea compared with the control after challenge (Debbink
et al., 2014). Our previous evaluations of adjuvanted GII.4 VLP
and P particle vaccines in Gn pigs demonstrated reductions
of diarrhea by 60 and 47%, respectively (Kocher et al., 2014).
Therefore, the probiotics plus RB cocktail regimens may provide
an alternative strategy with better anti-HuNoV effects than the
current vaccine candidates.
In summary, lactobacilli and EcN could bind to HuNoV
P particles and virions derived from GII.3 and GII.4 clinical
samples. Colonization with LGG+EcN completely inhibited
HuNoV fecal shedding in Gn pigs. The two cocktail regimens
had RB feeding started either 7 days prior to or 1 day after
viral inoculation in the LGG+EcN colonized Gn pigs, and
both regimens exhibited dramatic anti-HuNoV effects, including
reduced incidence and shorter duration of diarrhea, as well as
shorter duration of virus fecal shedding. The anti-HuNoV effects
of the cocktail regimens were associated with the stimulated IFN-
γ+ T cell responses, increased production of intestinal IgA and
IgG, and longer villus length. Considering the natural source
and commercial availability of probiotics and RB, the cocktail
regimens may represent a novel, safe and ready-to-use strategy
against diarrhea and infection caused by HuNoV infection and
other enteric pathogens.
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